Beryl Drugs informs about disclosure
Beryl Drugs has informed that the Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi.
The above information is a part of company’s filings submitted to BSE.
